Heparan sulfate mimetic compounds in modulating RRV as potential therapies   — ASN Events
  1. Schedule
  2. Poster Session II
  3. Heparan sulfate mimetic compounds in modulating RRV as potential therapies  

Heparan sulfate mimetic compounds in modulating RRV as potential therapies   (#376)

Aroon Supramaniam 1 , Vito Ferro 2 3 , Lara Herrero 1
  1. Griffith University, Parkwood, QLD, Australia
  2. School of Chemistry & Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia
  3. Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland, Australia
Publish consent withheld
  1. Supramaniam A, Liu X, Ferro V, Herrero LJ. 2018. Prophylactic antiheparanase activity by PG545 is antiviral in vitro and protects against Ross River virus disease in mice. Antimicrob Agents Chemother 62:e01959-17. https://doi.org/10.1128/AAC.01959-17.
#2018ASM